Dose Painting of Head and Neck Cancer (RADPAINT)

NCT03847480

Contact: Einar Dale, MD PhD, +4722934000
Contact: Cecilie Amdal, MD PhD, +4722934000
 
 
Brief Summary:
 
Dose-painting may increase the chance of cure at minimised radiation-induced toxicity in volumetric-arc radiotherapy (VMAT) for head and neck cancer. This trial (RADPAINT) investigates the safety of FDG-PET guided radiotherapy using VMAT dose-painting by contours for patients with head and neck cancer of poor prognosis.
 
Scroll to top